Related Experiment Video
Updated: Jul 14, 2026
07:36
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
[Mineralocorticoid resistance: pseudohypoaldosteronism type 1]
Fábio L Fernandes-Rosa1, Sonir R R Antonini
1Departamento de Puericultura e Pediatria, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, SP.
Arquivos Brasileiros De Endocrinologia E Metabologia
|June 5, 2007
Summary
Pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disorder causing salt wasting. This review details PHA1 mechanisms, clinical findings, and genetic mutations, including a Brazilian family with a mineralocorticoid receptor gene mutation.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disorder.
- It is characterized by salt wasting, vomiting, dehydration, and failure to thrive in neonates.
- Patients exhibit hyponatremia and hyperkalemia due to aldosterone resistance.
Observation:
- Two forms exist: systemic (severe, autosomal recessive, ENaC gene mutations) and renal (mild, often autosomal dominant, mineralocorticoid receptor gene mutations).
- Systemic PHA1 requires high salt supplementation and presents lifelong symptoms.
- Renal PHA1 typically improves within the first year with low-dose salt supplementation.
Findings:
- This review discusses aldosterone action mechanisms and effects.
- Clinical and molecular data from a Brazilian family with renal PHA1 are presented.
- A nonsense mutation (R947X) in the mineralocorticoid receptor gene was identified in the Brazilian family.
Implications:
- Understanding PHA1 genetics and aldosterone resistance is crucial for diagnosis and management.
- Identifying specific mutations aids in predicting disease severity and prognosis.
- Further research into aldosterone pathways may reveal new therapeutic targets.
Related Concept Videos
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:24Renal Tubule and Collecting Duct
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...